Skip to main content
Clinical Trials/JPRN-jRCT1040220010
JPRN-jRCT1040220010
Recruiting
未知

An observational study on treatment patterns and outcomes among patients with metastatic or recurrent esophageal cancer: Real world data and empirical analysis in Japan - POME

Kei Muro0 sites1,000 target enrollmentApril 23, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
esophageal cancer
Sponsor
Kei Muro
Enrollment
1000
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 23, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kei Muro

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients diagnosed with metastatic or recurrent esophageal squamous or adenosquamous cancer from January 1, 2013 to December 31, 2018
  • 2\. Age: 20 years or older
  • 3\. Patients in the above categories (1\) to (4\) of patients eligible for chemotherapy for esophageal cancer from January 2013 to the end of December 2018 who have received chemotherapy for metastasis or recurrence
  • 4\. Patients from whom appropriate consent is obtained (see General Informed Consent)
  • All inclusion and exclusion criteria will be reviewed by the investigator or qualified designee to ensure that the subject qualifies for the study.

Exclusion Criteria

  • Patients who were registered in a clinical study at the time of the first chemotherapy treatment for metastatic or recurrent esophageal cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials